A new weekly insulin injection may soon replace daily shots for type 2 diabetes patients, potentially reducing the number of injections by 86%. The treatment is currently awaiting approval from the Medicines and Healthcare products Regulatory Agency before it can be made available on the NHS.
Diabetes UK highlights that this innovation could significantly improve management for individuals with additional care needs, such as those with mobility issues or cognitive challenges, who struggle with daily injections.
Watch for the MHRA's decision on the weekly insulin jab, as its approval could revolutionize diabetes management for those with mobility or cognitive challenges. This shift may also prompt discussions on equitable access to diabetes care across the UK healthcare systems.